Rule 170 of the Drugs and Cosmetics Rules
On 27th August, 2024, the Supreme Court of India, while hearing the case against Patanjali Ayurved, pulled up the AYUSH Ministry for its July 1, 2024, notification asking state licensing authorities “not to initiate/take any action under” Rule 170 of the Drugs and Cosmetics Act, 1940.
What is Rule 170?
- Introduction Date: It was introduced in 2018 to govern the manufacture, storage, and sale of medicines in the country, “specifically for controlling inappropriate advertisements of Ayurvedic, Siddha and Unani medicines”.
- Rationale: The rule was introduced after a parliamentary standing committee highlighted the problem of misleading claims, and the need for the ....
Do You Want to Read More?
Subscribe Now
To get access to detailed content
Already a Member? Login here
Take Annual Subscription and get the following Advantage
The annual members of the Civil Services Chronicle can read the monthly content of the magazine as well as the Chronicle magazine archives.
Readers can study all the material since 2018 of the Civil Services Chronicle monthly issue in the form of Chronicle magazine archives.
India Watch
- 1 ‘Anna Chakra’: Optimizing PDS Supply chain
- 2 CAG Report on the 74th Constitutional Amendment Act
- 3 Global India Authorised Economic Operator Programme
- 4 Parliamentary Committee to Examine the Issue of Lateral Entry
- 5 Sagarmanthan 2024: India’s Maritime Vision
- 6 State Finance Commissions
- 7 SC’s Guidelines on Illegal Demolition of Private Property
- 8 PM-JAY: SC Directs Inclusion of Ayurveda, Yoga & Naturopathy
- 9 UP Madarsa Education Board Act Constitutionally Valid:SC
- 10 DRI Report on Smuggling